FDA reviewers were divided over Stealth’s data before Barth drug approvalnews2025-11-05T20:15:07+00:00November 5th, 2025|Endpoints News|
FTC raises concerns about structure of Novo Nordisk’s bid for Metseranews2025-11-05T19:49:59+00:00November 5th, 2025|Endpoints News|
Supernus halts delivery of some Parkinson’s pumps over supply constraintsnews2025-11-05T18:05:08+00:00November 5th, 2025|Endpoints News|
Teva CEO says IRA drug price negotiations met expectationsnews2025-11-05T17:52:56+00:00November 5th, 2025|Endpoints News|
FDA rejects Biohaven’s ataxia drug, shutting down company’s second attempt to win approvalnews2025-11-05T16:39:16+00:00November 5th, 2025|Endpoints News|
Recursion CEO Chris Gibson to step down in 2026news2025-11-05T16:20:12+00:00November 5th, 2025|Endpoints News|
Nobel laureate David Baker on Nature paper for AI antibody modelnews2025-11-05T16:00:50+00:00November 5th, 2025|Endpoints News|
Zealand CEO calls on industry to end the ‘weight loss Olympics’news2025-11-05T16:00:29+00:00November 5th, 2025|Endpoints News|
Hepta raises $6.7M to take liquid biopsy into liver diseasenews2025-11-05T16:00:04+00:00November 5th, 2025|Endpoints News|
Lilly partners with AI biologics company; Amgen ends gastric cancer studynews2025-11-05T15:27:32+00:00November 5th, 2025|Endpoints News|
